# Nexus Pharmaceuticals, LLC 401(k) Plan
Source: https://planprovider.pro/companies/nexus-pharmaceuticals-inc-401k-plan

> Nexus Pharmaceuticals, LLC&#39;s 401(k) plan: 94 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Nexus Pharmaceuticals, LLC

- **Sponsor EIN:** 200324645

- **Sponsor Address:** 400 KNIGHTSBRIDGE PARKWAY, LINCOLNSHIRE, IL, 60069

- **Plan Type:** 401(k)

- **Total Participants:** 94

- **Total Assets:** $12.3M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** No

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|94|$12.3M|$536,683|$1.4M|

| 2023|203|$16.0M|$706,557|$1.6M|

| 2022|195|$12.1M|$784,706|$1.3M|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| RSM US LLP|Auditor|—|—|$0|

### Verified Provider Profiles

Direct links to verified profiles of matched retirement plan providers on PlanProvider.Pro:

- [RSM US LLP](https://planprovider.pro/provider/rsm-us-llp) — Auditor

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $0

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$66,446|$34,838|—|—|—|

| 2023|$60,243|$32,800|—|—|—|

| 2022|$51,887|$30,340|—|—|—|

## Similar Plans

- [Paragon Biosciences LLC](https://planprovider.pro/companies/paragon-biosciences-llc-401k-plan) — 91 participants

- [Regis Technologies, INC.](https://planprovider.pro/companies/regis-technologies-inc-401k-plan) — 75 participants

- [Sagent Pharmaceuticals INC](https://planprovider.pro/companies/sagent-pharmaceuticals-inc-401k-plan) — 119 participants

- [Assertio Management, LLC](https://planprovider.pro/companies/assertio-management-llc-401k-plan-001-2867) — 57 participants

- [Tersera Therapeutics LLC](https://planprovider.pro/companies/tersera-therapeutics-llc-401k-plan) — 160 participants

- [Abbott Laboratories](https://planprovider.pro/companies/abbott-laboratories-plan-300) — 161 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/nexus-pharmaceuticals-inc-401k-plan)

&copy; 2026 PlanProvider.Pro
